Literature DB >> 16860614

Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis.

Amir F Kagalwalla1, Timothy A Sentongo, Sally Ritz, Therese Hess, Suzanne P Nelson, Karan M Emerick, Hector Melin-Aldana, B U K Li.   

Abstract

BACKGROUND & AIMS: In children, eosinophilic esophagitis (EE) is predominantly, but not exclusively, a food-hypersensitivity disorder. A crystalline amino acid-based elemental diet (ELED) formula currently remains the most effective nutritional treatment in inducing clinical and histologic remission. However, compliance with an exclusive, poor-tasting liquid formulation is difficult.
METHODS: This retrospective observational study assessed the short-term clinical and histologic responses of 2 cohorts of children with EE evaluated during 2 different time periods: one was treated with the standard 6-food elimination diet (SFED) and the other was treated with ELED. Of the 60 children who met the inclusion criteria and were compliant with the dietary protocol, 35 were treated with a diet excluding cow-milk protein, soy, wheat, egg, peanut, and seafood while allowing all other table foods and 25 were treated exclusively with ELED. Repeat esophageal biopsy specimens were obtained at least 6 weeks later.
RESULTS: Twenty-six of 35 (74%) in the SFED group and 22 of 25 (88%) in the ELED group achieved significant improvement of esophageal inflammation (</=10 eosinophils/high-power field). The pretreatment and posttreatment peak eosinophil counts for the SFED were 80.2 +/- 44.0 and 13.6 +/- 23.8 (P < .0001) and 58.8 +/- 31.9 and 3.7 +/- 6.5 (P < .001) for the ELED group, respectively.
CONCLUSIONS: SFED treatment was associated with clinical and histologic improvement in EE in an observational study. It offers advantages of better acceptance, cost, and compliance than ELED and should be considered as an option in the initial management of children with EE.

Entities:  

Mesh:

Year:  2006        PMID: 16860614     DOI: 10.1016/j.cgh.2006.05.026

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  208 in total

1.  Involvement of mast cells in eosinophilic esophagitis.

Authors:  J Pablo Abonia; Carine Blanchard; Bridget Buckmeier Butz; Heather F Rainey; Margaret H Collins; Keith Stringer; Philip E Putnam; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-06-09       Impact factor: 10.793

2.  Eosinophilic esophagitis in children and adults.

Authors:  Glenn T Furuta
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-11

Review 3.  Diagnosis and management of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 11.382

Review 4.  Management of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approaches.

Authors:  Bharati Kochar; Evan S Dellon
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-09-12       Impact factor: 3.869

Review 5.  Eosinophilic Esophagitis.

Authors:  Glenn T Furuta; David A Katzka
Journal:  N Engl J Med       Date:  2015-10-22       Impact factor: 91.245

Review 6.  Role of Endoscopy in Diagnosis and Management of Pediatric Eosinophilic Esophagitis.

Authors:  Amanda B Muir; Jamie Merves; Chris A Liacouras
Journal:  Gastrointest Endosc Clin N Am       Date:  2016-01

Review 7.  The Role of the Environment in Eosinophilic Esophagitis.

Authors:  Paul J Dowling; Hannah Neuhaus; Brooke I Polk
Journal:  Clin Rev Allergy Immunol       Date:  2019-12       Impact factor: 8.667

8.  Longitudinal Growth Outcomes Following First-line Treatment for Pediatric Patients With Eosinophilic Esophagitis.

Authors:  Elizabeth T Jensen; Kevin Z Huang; Hannah X Chen; Lisa E Landes; Kristen A McConnell; Mary Angie Almond; Anca M Safta; Douglas T Johnston; Raquel Durban; Laura Jobe; Carrie Frost; Sarah Donnelly; Brady Antonio; Antonio Quiros; Jonathan E Markowitz; Evan S Dellon
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-01       Impact factor: 2.839

Review 9.  Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.

Authors:  Mery Munoz-Persy; Alfredo J Lucendo
Journal:  Eur J Pediatr       Date:  2018-03-17       Impact factor: 3.183

Review 10.  Eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Gastroenterol Clin North Am       Date:  2012-12-27       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.